Growth inhibitory effects of 5-aza-2′-deoxycytidine in HL-60 promyelocytic leukemia cells resistant to differentiation induction
Authors:
- Albert LevvaALAlbert Levva
- Gilberto SchwartsmannGSGilberto Schwartsmann
- Leonie C.M. BoeijeLBLeonie C.M. Boeije
- Herbert M. PinedoHPHerbert M. Pinedo
- Frans de WaalFWFrans de Waal
- 1 December 1986
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 141 (2) , 629-635
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Comparison of the in vitro cytotoxicity (L1210) of 5-Aza-2′-deoxycytidine with its therapeutic and toxic effects in miceEuropean Journal of Cancer and Clinical Oncology, 1985
- Comparison of the antileukemic activity of 5-aza-2′-deoxycytidine, 1-β-d-arabinofuranosylcytosine and 5-azacytidine against L1210 leukemiaLeukemia Research, 1984
- Cell kinetic responses in childhood acute nonlymphocytic leukemia during high-dose therapy with cytosine arabinosideBlood, 1983
- Inhibition of DNA methyltransferase and induction of Friend erythroleukemia cell differentiation by 5-azacytidine and 5-aza-2'-deoxycytidine.Journal of Biological Chemistry, 1982
- Phase I study on 5-aza-2′-deoxycytidine in children with acute leukemiaLeukemia Research, 1981
- Cellular differentiation, cytidine analogs and DNA methylationCell, 1980
- Induction of morphological and functional differentiation of human promyelocytic leukemia cells (HL‐60) by compounds which induce differentiation of murine leukemia cellsInternational Journal of Cancer, 1980
- The molecular basis of drug-induced G2 arrest in mammalian cellsMolecular and Cellular Biochemistry, 1980
- Continuous growth and differentiation of human myeloid leukaemic cells in suspension cultureNature, 1977